10月9日丨海正藥業(600267.SH) -0.110 (-1.058%) 公佈,公司產品1,4-丁二磺酸腺苷蛋氨酸,按照美國FDA GRAS準則完成Self-GRAS(Self-affirmed Generallyrecognized as safe)科學評價並獲得專家組一致批准,正式通過美國Self-GRAS認證。